What is BioSAFE Engineering?
BioSAFE Engineering is a global leader in the design, manufacture, installation, and service of waste treatment equipment. Their solutions are critical for research facilities, healthcare, industry, and science, focusing on the elimination of hazardous or infectious agents. Tracing its origins to 1993, the company pioneered alkaline hydrolysis technology for laboratory waste decontamination, offering an alternative to commercial incineration. Since its re-capitalization and rebranding in 2007, BioSAFE Engineering has expanded its offerings to include Effluent Decontamination Systems (EDS), which treat bio-hazardous effluents and waterborne pathogens, solidifying its reputation as a premier provider of incinerator replacement technologies.
How much funding has BioSAFE Engineering raised?
BioSAFE Engineering has raised a total of $725K across 2 funding rounds:
Debt
$350K
Debt
$375K
Debt (2020): $350K with participation from PPP
Debt (2021): $375K led by PPP
What's next for BioSAFE Engineering?
The recent major strategic investment signals a phase of significant growth and potential expansion for BioSAFE Engineering. With a strong foundation in alkaline hydrolysis and a proven track record in developing advanced Effluent Decontamination Systems, the company is well-positioned to further its market leadership. Future endeavors will likely focus on scaling manufacturing capabilities, enhancing research and development for next-generation waste treatment solutions, and potentially exploring new market segments that require robust bio-hazardous waste management. This strategic financing will be instrumental in supporting these ambitious objectives and reinforcing BioSAFE Engineering's commitment to safety and environmental stewardship.
See full BioSAFE Engineering company page
